Neuroendocrine differentiation is a hallmark of prostate cancer. The aim of our study was the detection of the parallel expression of neuroendocrine related markers using a prostate tissue microarray (TMA)
In vitro studies have implicated neuroendocrine differentiation in the development of hormone resist...
Neuroendocrine (NE) differentiation, either benign or malignant, is the hallmark of prostate cancer ...
International audienceObjectives: To determine whether small cell neuroendocrine prostate cancers (N...
Neuroendocrine differentiation is a hallmark of prostate cancer. The aim of our study was the detect...
Neuroendocrine differentiation is a hallmark of prostate cancer. The aim of our study was the detect...
Neuroendocrine differentiation is a hallmark of prostate cancer. The aim of our study was the detect...
Neuroendocrine differentiation is a hallmark of prostate cancer. The aim of our study was the detect...
OBJECTIVES: Neuroendocrine differentiation is a common feature of prostate cancer (pCA). NeuroD1 is ...
OBJECTIVES: Neuroendocrine differentiation is a common feature of prostate cancer (pCA). NeuroD1 is ...
OBJECTIVES: Neuroendocrine differentiation is a common feature of prostate cancer (pCA). NeuroD1 is ...
Chromogranin A (CgA) is considered as a major specific neuroendocrine tumor marker. It belongs to th...
textabstractThe presence of androgen receptors (AR) in neuroendocrine cells was investigated in beni...
Neuroendocrine serum markers released from prostate cancers have been proposed for monitoring diseas...
In vitro studies have implicated neuroendocrine differentiation in the development of hormone resist...
Neuroendocrine serum markers released from prostate cancers have been proposed for monitoring diseas...
In vitro studies have implicated neuroendocrine differentiation in the development of hormone resist...
Neuroendocrine (NE) differentiation, either benign or malignant, is the hallmark of prostate cancer ...
International audienceObjectives: To determine whether small cell neuroendocrine prostate cancers (N...
Neuroendocrine differentiation is a hallmark of prostate cancer. The aim of our study was the detect...
Neuroendocrine differentiation is a hallmark of prostate cancer. The aim of our study was the detect...
Neuroendocrine differentiation is a hallmark of prostate cancer. The aim of our study was the detect...
Neuroendocrine differentiation is a hallmark of prostate cancer. The aim of our study was the detect...
OBJECTIVES: Neuroendocrine differentiation is a common feature of prostate cancer (pCA). NeuroD1 is ...
OBJECTIVES: Neuroendocrine differentiation is a common feature of prostate cancer (pCA). NeuroD1 is ...
OBJECTIVES: Neuroendocrine differentiation is a common feature of prostate cancer (pCA). NeuroD1 is ...
Chromogranin A (CgA) is considered as a major specific neuroendocrine tumor marker. It belongs to th...
textabstractThe presence of androgen receptors (AR) in neuroendocrine cells was investigated in beni...
Neuroendocrine serum markers released from prostate cancers have been proposed for monitoring diseas...
In vitro studies have implicated neuroendocrine differentiation in the development of hormone resist...
Neuroendocrine serum markers released from prostate cancers have been proposed for monitoring diseas...
In vitro studies have implicated neuroendocrine differentiation in the development of hormone resist...
Neuroendocrine (NE) differentiation, either benign or malignant, is the hallmark of prostate cancer ...
International audienceObjectives: To determine whether small cell neuroendocrine prostate cancers (N...
DOI
Add to ORKG